About the Organoids and 3D Bioprinting in Cancer Models Session
Organoids and 3D bioprinting represent groundbreaking innovations in cancer research, providing more accurate and dynamic models to study cancer biology. Organoids are miniature, three-dimensional versions of human organs, grown from stem cells, that mimic the tissue structure and function of real tumors. These models allow researchers to study cancer in a more in vivo-like environment, offering insights into tumor growth, drug responses, and metastasis that traditional cell cultures could not provide. 3D bioprinting, on the other hand, enables the creation of customized tumor models by printing living cells layer by layer, facilitating a more precise replication of human cancer. Both technologies offer a more reliable platform for testing potential therapies and understanding the complexity of cancer, thus accelerating the development of personalized medicine and improving treatment strategies.
Topics Covered in Organoids and 3D Bioprinting in Cancer Models
Patient-Derived Organoids
Bioprinted Tumor Models
Bioink Design
Microfluidic Tumor Chips
Immune Cell Coculture
Drug Sensitivity Testing
Related Scientific Sessions at CIOC 2027
Why Attend the Organoids and 3D Bioprinting in Cancer Models Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Organoids and 3D Bioprinting in Cancer Models work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Organoids and 3D Bioprinting in Cancer Models research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Organoids and 3D Bioprinting in Cancer Models track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Organoids and 3D Bioprinting in Cancer Models Conference 2027 — FAQs
What is the Organoids and 3D Bioprinting in Cancer Models track at CIOC 2027?
The Organoids and 3D Bioprinting in Cancer Models track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Organoids and 3D Bioprinting in Cancer Models. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Organoids and 3D Bioprinting in Cancer Models sessions?
Cancer researchers and clinicians, educators and students with an interest in Organoids and 3D Bioprinting in Cancer Models are all welcome — whether presenting or attending.
Can I present my research in the Organoids and 3D Bioprinting in Cancer Models track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Organoids and 3D Bioprinting in Cancer Models sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Organoids and 3D Bioprinting in Cancer Models track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.